Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers

Sherif Abdel-Rahman, Randa A. El-Zein, Joseph B. Zwischenberger, William W. Au

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The NAT1 gene exhibits polymorphisms in the non-coding polyadenylation region with a number of alleles. Of these alleles, NAT1*10 is responsible for increased NAT1 enzyme levels and is reported to be associated with increased risk for colorectal and bladder cancers. In view of the possible role of the NAT1 gene product in the metabolism of a number of cigarette smoke carcinogens, we tested the possibility that genetic variation in the NAT1 gene might also be associated with increased risk for lung cancer. Allelic variances of the NAT1 gene were analyzed in 45 lung cancer patients and 47 controls wile were matched with respect to age, race and gender using restriction fragment length polymorphism (RFLP) analysis and allele-specific (AS)-PCR. Our results indicate that individuals who inherited the NAT1*10 allele had a 3.7-fold increased relative risk for lung cancer (95% CL = 1.2-16.0, p < 0.02). There was a 6.8-fold increase in relative risk for lung cancer associated with the inheritance of the NAT1*10 allele in younger individuals (< 60 years of age) compared to 2.2-fold increase in older individuals (> 60 years old) (OR = 6.8; 95% CL = 1.1-40.7, p < 0.01 and OR = 2.2; 95% CL = 0.5-11.1, p = 0.2 respectively). We have also applied the sensitive fluorescence in situ hybridization (FISH) tandem probe assay to elucidate the frequency of chromosome breakage among a subgroup of the studied individuals harboring the NAT1*10 allele (17 lung cancer patients, 17 smoking controls and 7 non-smoking controls). Our results indicate a significant increase (P < 0.001) in the frequency of chromosome breaks in lung cancer patients (mean ± SE per 100 cells = 1.45 ± 0.11) and in smoking controls (1.30 ± 0.13) compared to non-smoking controls (0.47 ± 0.07). Regression analysis indicated a highly significant positive correlation between the duration of smoking in years and the frequency of chromosome breaks in lung cancer patients (r = 0.62, p = 0.008), but not in smoking controls (r = 0.02; p = 0.91). These findings suggest that NAT1 polymorphism may be an important genetic determinant of lung cancer risk. In addition, these data provide a mechanistic link between the inheritance of the NAT1*10 allele and smoking-induced lung cancer. Given that the NAT1 enzyme can mediate activation and detoxication pathways for numerous carcinogens and given that this polymorphism is prevalent in the general population (20-50% frequency), it may play a significant role in influencing the outcome of a variety of environmental cancers.

Original languageEnglish (US)
Pages (from-to)43-54
Number of pages12
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume398
Issue number1-2
DOIs
StatePublished - Feb 28 1998
Externally publishedYes

Fingerprint

Tobacco Products
Chromosome Aberrations
Lung Neoplasms
Genotype
Alleles
Chromosome Breakage
Smoking
Carcinogens
Genes
Polyadenylation
Enzymes
Fluorescence In Situ Hybridization
Urinary Bladder Neoplasms
Smoke
Restriction Fragment Length Polymorphisms
Colorectal Neoplasms
Regression Analysis
Polymerase Chain Reaction
Population
Neoplasms

Keywords

  • Acetylation
  • Allele specific PCR
  • Chromosome aberration
  • FISH
  • Genetic polymorphism
  • Lung cancer
  • Metabolism
  • NAT1
  • PCR
  • RFLP
  • Smoking

ASJC Scopus subject areas

  • Molecular Biology
  • Health, Toxicology and Mutagenesis

Cite this

Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. / Abdel-Rahman, Sherif; A. El-Zein, Randa; Zwischenberger, Joseph B.; Au, William W.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 398, No. 1-2, 28.02.1998, p. 43-54.

Research output: Contribution to journalArticle

@article{3f2dc477dd144a57bae07d1d5da0f9a9,
title = "Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers",
abstract = "The NAT1 gene exhibits polymorphisms in the non-coding polyadenylation region with a number of alleles. Of these alleles, NAT1*10 is responsible for increased NAT1 enzyme levels and is reported to be associated with increased risk for colorectal and bladder cancers. In view of the possible role of the NAT1 gene product in the metabolism of a number of cigarette smoke carcinogens, we tested the possibility that genetic variation in the NAT1 gene might also be associated with increased risk for lung cancer. Allelic variances of the NAT1 gene were analyzed in 45 lung cancer patients and 47 controls wile were matched with respect to age, race and gender using restriction fragment length polymorphism (RFLP) analysis and allele-specific (AS)-PCR. Our results indicate that individuals who inherited the NAT1*10 allele had a 3.7-fold increased relative risk for lung cancer (95{\%} CL = 1.2-16.0, p < 0.02). There was a 6.8-fold increase in relative risk for lung cancer associated with the inheritance of the NAT1*10 allele in younger individuals (< 60 years of age) compared to 2.2-fold increase in older individuals (> 60 years old) (OR = 6.8; 95{\%} CL = 1.1-40.7, p < 0.01 and OR = 2.2; 95{\%} CL = 0.5-11.1, p = 0.2 respectively). We have also applied the sensitive fluorescence in situ hybridization (FISH) tandem probe assay to elucidate the frequency of chromosome breakage among a subgroup of the studied individuals harboring the NAT1*10 allele (17 lung cancer patients, 17 smoking controls and 7 non-smoking controls). Our results indicate a significant increase (P < 0.001) in the frequency of chromosome breaks in lung cancer patients (mean ± SE per 100 cells = 1.45 ± 0.11) and in smoking controls (1.30 ± 0.13) compared to non-smoking controls (0.47 ± 0.07). Regression analysis indicated a highly significant positive correlation between the duration of smoking in years and the frequency of chromosome breaks in lung cancer patients (r = 0.62, p = 0.008), but not in smoking controls (r = 0.02; p = 0.91). These findings suggest that NAT1 polymorphism may be an important genetic determinant of lung cancer risk. In addition, these data provide a mechanistic link between the inheritance of the NAT1*10 allele and smoking-induced lung cancer. Given that the NAT1 enzyme can mediate activation and detoxication pathways for numerous carcinogens and given that this polymorphism is prevalent in the general population (20-50{\%} frequency), it may play a significant role in influencing the outcome of a variety of environmental cancers.",
keywords = "Acetylation, Allele specific PCR, Chromosome aberration, FISH, Genetic polymorphism, Lung cancer, Metabolism, NAT1, PCR, RFLP, Smoking",
author = "Sherif Abdel-Rahman and {A. El-Zein}, Randa and Zwischenberger, {Joseph B.} and Au, {William W.}",
year = "1998",
month = "2",
day = "28",
doi = "10.1016/S0027-5107(97)00238-8",
language = "English (US)",
volume = "398",
pages = "43--54",
journal = "Mutation Research",
issn = "0027-5107",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers

AU - Abdel-Rahman, Sherif

AU - A. El-Zein, Randa

AU - Zwischenberger, Joseph B.

AU - Au, William W.

PY - 1998/2/28

Y1 - 1998/2/28

N2 - The NAT1 gene exhibits polymorphisms in the non-coding polyadenylation region with a number of alleles. Of these alleles, NAT1*10 is responsible for increased NAT1 enzyme levels and is reported to be associated with increased risk for colorectal and bladder cancers. In view of the possible role of the NAT1 gene product in the metabolism of a number of cigarette smoke carcinogens, we tested the possibility that genetic variation in the NAT1 gene might also be associated with increased risk for lung cancer. Allelic variances of the NAT1 gene were analyzed in 45 lung cancer patients and 47 controls wile were matched with respect to age, race and gender using restriction fragment length polymorphism (RFLP) analysis and allele-specific (AS)-PCR. Our results indicate that individuals who inherited the NAT1*10 allele had a 3.7-fold increased relative risk for lung cancer (95% CL = 1.2-16.0, p < 0.02). There was a 6.8-fold increase in relative risk for lung cancer associated with the inheritance of the NAT1*10 allele in younger individuals (< 60 years of age) compared to 2.2-fold increase in older individuals (> 60 years old) (OR = 6.8; 95% CL = 1.1-40.7, p < 0.01 and OR = 2.2; 95% CL = 0.5-11.1, p = 0.2 respectively). We have also applied the sensitive fluorescence in situ hybridization (FISH) tandem probe assay to elucidate the frequency of chromosome breakage among a subgroup of the studied individuals harboring the NAT1*10 allele (17 lung cancer patients, 17 smoking controls and 7 non-smoking controls). Our results indicate a significant increase (P < 0.001) in the frequency of chromosome breaks in lung cancer patients (mean ± SE per 100 cells = 1.45 ± 0.11) and in smoking controls (1.30 ± 0.13) compared to non-smoking controls (0.47 ± 0.07). Regression analysis indicated a highly significant positive correlation between the duration of smoking in years and the frequency of chromosome breaks in lung cancer patients (r = 0.62, p = 0.008), but not in smoking controls (r = 0.02; p = 0.91). These findings suggest that NAT1 polymorphism may be an important genetic determinant of lung cancer risk. In addition, these data provide a mechanistic link between the inheritance of the NAT1*10 allele and smoking-induced lung cancer. Given that the NAT1 enzyme can mediate activation and detoxication pathways for numerous carcinogens and given that this polymorphism is prevalent in the general population (20-50% frequency), it may play a significant role in influencing the outcome of a variety of environmental cancers.

AB - The NAT1 gene exhibits polymorphisms in the non-coding polyadenylation region with a number of alleles. Of these alleles, NAT1*10 is responsible for increased NAT1 enzyme levels and is reported to be associated with increased risk for colorectal and bladder cancers. In view of the possible role of the NAT1 gene product in the metabolism of a number of cigarette smoke carcinogens, we tested the possibility that genetic variation in the NAT1 gene might also be associated with increased risk for lung cancer. Allelic variances of the NAT1 gene were analyzed in 45 lung cancer patients and 47 controls wile were matched with respect to age, race and gender using restriction fragment length polymorphism (RFLP) analysis and allele-specific (AS)-PCR. Our results indicate that individuals who inherited the NAT1*10 allele had a 3.7-fold increased relative risk for lung cancer (95% CL = 1.2-16.0, p < 0.02). There was a 6.8-fold increase in relative risk for lung cancer associated with the inheritance of the NAT1*10 allele in younger individuals (< 60 years of age) compared to 2.2-fold increase in older individuals (> 60 years old) (OR = 6.8; 95% CL = 1.1-40.7, p < 0.01 and OR = 2.2; 95% CL = 0.5-11.1, p = 0.2 respectively). We have also applied the sensitive fluorescence in situ hybridization (FISH) tandem probe assay to elucidate the frequency of chromosome breakage among a subgroup of the studied individuals harboring the NAT1*10 allele (17 lung cancer patients, 17 smoking controls and 7 non-smoking controls). Our results indicate a significant increase (P < 0.001) in the frequency of chromosome breaks in lung cancer patients (mean ± SE per 100 cells = 1.45 ± 0.11) and in smoking controls (1.30 ± 0.13) compared to non-smoking controls (0.47 ± 0.07). Regression analysis indicated a highly significant positive correlation between the duration of smoking in years and the frequency of chromosome breaks in lung cancer patients (r = 0.62, p = 0.008), but not in smoking controls (r = 0.02; p = 0.91). These findings suggest that NAT1 polymorphism may be an important genetic determinant of lung cancer risk. In addition, these data provide a mechanistic link between the inheritance of the NAT1*10 allele and smoking-induced lung cancer. Given that the NAT1 enzyme can mediate activation and detoxication pathways for numerous carcinogens and given that this polymorphism is prevalent in the general population (20-50% frequency), it may play a significant role in influencing the outcome of a variety of environmental cancers.

KW - Acetylation

KW - Allele specific PCR

KW - Chromosome aberration

KW - FISH

KW - Genetic polymorphism

KW - Lung cancer

KW - Metabolism

KW - NAT1

KW - PCR

KW - RFLP

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=0032567837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032567837&partnerID=8YFLogxK

U2 - 10.1016/S0027-5107(97)00238-8

DO - 10.1016/S0027-5107(97)00238-8

M3 - Article

VL - 398

SP - 43

EP - 54

JO - Mutation Research

JF - Mutation Research

SN - 0027-5107

IS - 1-2

ER -